Small caps

Endexx (OTC: EDXC) recently announced it will be participating in the first annual WeedStock Conference, presented by Marketfy. Endexx is best known in the cannabis industry for its “Seed-to-Sale” software, M3Hub. This technology tracks every notable touchpoint of marijuana...

In an interview with Benzinga, Aldeyra Therapeutics (NASDAQ: ALDX) CEO Dr. Todd Brady discussed his company’s opportunities. “What we have is an aldehyde trap,” began Brady. “We developed molecules that bind to and dispose of aldehyde.” Aldehydes are an agent in...

In an exclusive interview with Benzinga, director of Investor Relations, Helen Yang, discussed Sinovac’s (NASDAQ: SVA) future opportunities. Sinovac is Chinese biopharmaceutical company which produces, among others, a hepatitis A and B vaccine and is currently preparing to commercialize...

Investors across the country are preparing to consider and adjust their investments in the cannabis space, following announcements they hear at the WeedStock conference, taking place from June 29 to July 1 in Denver. One of the biggest aspects many investors are anticipating is the discussion...

As the market continues to make all time highs every day, it can be hard to find value stocks. To weed out stocks that look valuable, but are cheaply priced because the company is crumbling, all the companies in this list have positive earnings over the past year and are expected to have year...

AnythingIT (OTC: ANYI) recently announced it will be participating in the first annual WeedStock Conference, presented by Marketfy. The conference will take place in Denver, Colorado, from June 29 through July 1 and will feature exclusive presentations by a collection of public and private...

In an interview with Benzinga, Oragenics (NYSE: OGEN) CEO John Bonfiglio discussed the company’s business and opportunities that lie ahead. Bonfiglio started by explaining Oragenics’ most active business line: the development of a new bacteriocin called lantibiotics. Bacteriocin are...

It comes as no secret to long term investors that the stock market is on the high side of fair value right now. The Schiller PE ratio is currently 25.9 which gives a forward return projection of less than one percent over the next five years. Ned Davis Research pointed out recently that the...

Chris Benedict, lead analyst of DataLend, gave Benzinga his updates on short interest for three of the hottest stocks in the market. NQ Mobile NQ Mobile (NYSE: NQ) has been one of the most controversial stocks of the past year. A Muddy Waters report on fraudulent activity sent shares down...

In an exclusive interview with Benzinga, Evoke Pharma (NASDAQ: EVOK) CEO Dave Gonyer discussed the company’s opportunities. Evoke is currently focused on its drug EVK-001. EVK-001 is a nasal spray to treat diabetic gastroparesis. Gonyer began by discussing the drug's potential market....

In an interview with Benzinga, Zix (NASDAQ: ZIXI) Chairman and CEO Rick Spurr discussed the company’s email encryption business. Zix has three primary offerings: A data loss prevention product to protect content that is trying to be maliciously distributed or stolen, a bring your own device...

Single Family Home (SFH) REITs are still relatively new, with the first appearing on the scene in late 2012. For those investors not familiar with these securities, they are publicly traded companies with a business model of purchasing single family homes (hopefully at a discount to fair value),...